Related Experiment Video
Updated: Jul 11, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Clinical variability and characteristic autoantibody profile in primary C1q complement deficiency
G Vassallo1, R W Newton, S E Chieng
1Department of Paediatric Neurology, Booth Hall Children's Hospital, Manchester, M9 7AA, UK.
Insights
C1q deficiency, a rare complement cascade defect, presents diverse clinical features and specific autoantibodies. Early diagnosis is crucial for managing this severe immunodeficiency.
Area of Science:
- Immunology
- Genetics
Background:
- C1q deficiency is a rare inherited disorder affecting the complement cascade's early stages.
- It is associated with increased susceptibility to infections and autoimmune diseases.
Observation:
- A large, consanguineous Pakistani family exhibited C1q deficiency across multiple generations.
- Affected individuals, including a father and five sons, displayed varied clinical manifestations.
Findings:
- Clinical presentations ranged from asymptomatic to severe bacterial infections and lupus-like syndromes affecting skin, kidneys, or CNS.
- Characteristic autoantibodies included anti-Sm and anti-Ro, but not anti-dsDNA.
Implications:
- Recognizing the broad spectrum of C1q deficiency clinical and autoantibody profiles is vital.
- Accurate diagnosis and timely management are essential for this life-threatening immunodeficiency.
Objectives:
C1q deficiency is a rare inherited defect in the early part of the complement cascade. In this report, we describe the varied clinical features of patients with this condition as well as the characteristic autoantibody profile.
Methods:
A large Pakistani family with a high degree of consanguinity is described in which the father and five sons have C1q deficiency, all with different clinical manifestations.
Results:
Clinical features of C1q deficiency can vary from almost no disease to fulminant bacterial infection and localized lupus-like skin, renal or CNS disease. Autoantibodies to ribonucleoproteins such as anti-Sm and Ro, but not dsDNA, were present.
Conclusions:
Awareness of the spectrum of clinical disease, autoantibody profiles and tests required to confirm the diagnosis of C1q deficiency are important if this life-threatening immunodeficiency disease is to be managed correctly.
More Related Videos
Related Concept Videos
Complement System
Hypersensitivity Reactions: Immune-Complex Reactions
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Myasthenia Gravis ll: Pathophysiology
Humoral Immune Responses

